Literature DB >> 20371003

Composite bone and soft tissue loss treated with distraction histiogenesis.

Michael J Beltran1, Leah M Ochoa, Richard M Graves, Joseph R Hsu.   

Abstract

The purpose of this article is to describe the use of shortening and angulation to manage composite bone and soft tissue loss associated with combat-related type IIIB open tibia fractures. Four patients underwent placement of a software-driven circular fixator with acute shortening and angulation to manage composite bone and soft tissue loss. Frames were applied using the Rings First Method, and an induced deformity was created with the soft tissue defect within the concavity. Distraction histiogenesis was utilized to restore limb length and regenerate soft tissues. Three patients had healed fractures and mature regenerate allowing frame removal, while one remained in his frame for further consolidation. Mechanical alignment and limb length were restored in all patients. No major frame adjustments were required and all distracted soft tissues healed without complication. The article concludes that composite bone and soft tissue loss is effectively managed with distraction histiogenesis and the use of a software-driven circular fixator.

Entities:  

Mesh:

Year:  2010        PMID: 20371003

Source DB:  PubMed          Journal:  J Surg Orthop Adv        ISSN: 1548-825X


  3 in total

1.  Challenges in definitive fracture management of blast injuries.

Authors:  Wade Gordon; Kevin Kuhn; Greg Staeheli; David Dromsky
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

Review 2.  Acute Shortening for Open Tibial Fractures with Bone and Soft Tissue Defects: Systematic Review of Literature.

Authors:  Konstantins Plotnikovs; Jevgenijs Movcans; Leonid Solomin
Journal:  Strategies Trauma Limb Reconstr       Date:  2022 Jan-Apr

3.  Conversion of open tibial IIIb to IIIa fractures using intentional temporary deformation and the Taylor Spatial Frame.

Authors:  H Sharma; T Nunn
Journal:  Strategies Trauma Limb Reconstr       Date:  2013-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.